Preliminary agenda noted below. The program also features a Networking Break and Lunch, and NCBIO Business Session.
TWO KEYNOTES: New Innovations: Personalized Health and Cancer Treatment Industry leader describes why these innovations have developed now, discusses the promise of the therapies, and highlights pricing and value.
Capital Formation and Market Trends
This keynote discusses best strategies to raise funding, the impact of current regulations on product pricing, and the ability of companies to continue to innovate. Take a deep dive into the economics of the life science space and the economic cross currents that industry is navigating.
TWO PANELS: Access and Availability
This interactive session features a discussion of policies necessary to make both novel and established therapies accessible to patients. Learn more about the realities and responsive policies that are maturing or effecting patient access including value-based reimbursement, pharmaceutical rebate reform, and other important topics.
Dora Hughes, M.D., M.P.H., Associate Research Professor, Department of Health Policy and Management, Milken Institute School of Public Health, The George Washington University
Jeff Kiser, Market Head of Sales and Service, Aetna
Robin Levy,Senior Director, Public Policy and Advocacy, International Myeloma Foundation
Marianne Lopez, Ph.D.,Research Director, Value-Based Payment Reform, Duke-Margolis Center for Health Policy (Moderator)